Evogene
Evogene (NASDAQ: EVGN, TASE: EVGN) is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters.
Nº Q6981538 ★★★
Rare · Organisations
Evogene
Evogene (NASDAQ: EVGN, TASE: EVGN) is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters.
Dernier prix
—
Prix plancher
—
Médiane 7 j
—
Ventes 30 j
0
Fourchette 30 j
—
En circulation
0
Cours
médiane
min – max
ventes
Aucune vente sur la période
Voir le tableau
| Date | médiane | Min | Max | ventes |
|---|
Historique des ventes
- Dernière vente
- —
- Moyenne 30 j
- —
- Plus bas 30 j
- —
- Plus haut 30 j
- —
- Ventes 7 j
- 0
- Ventes 30 j
- 0
Aucune vente pour l'instant.
Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.
Sur Wikipédia
Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.
Evogene (NASDAQ: EVGN, TASE: EVGN) is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.
Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Litalmam (CC BY-SA 4.0) ·
Cartes voisines
Compugen
Publicly traded Israeli drug discovery company
Nº Q5157220 ★★★
Argenx
Société belgo-néerlandaise spécialisée dans l’immunologie
Nº Q63152908 ★★
Evotec
Entreprise allemande
Nº Q1382629 ★★★
Chromagen
Israeli company
Nº Q16340297 ★★★
Watergen
Israel-based global company that develops water-from-air solutions
Nº Q85814615 ★★★
Biogen
Entreprise pharmaceutique américaine
Nº Q864338 ★★